105 related articles for article (PubMed ID: 217544)
21. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
Callahan J; Pai S; Cotter M; Robertson ES
Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
[TBL] [Abstract][Full Text] [Related]
22. A comparison of Epstein-Barr virus specific proteins expressed by three Epstein-Barr virus isolates using specific monoclonal antibodies.
Tsai CH; Glaser R
Intervirology; 1991; 32(6):376-82. PubMed ID: 1657827
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus induced proteins V: comparison of EBV-specific polypeptides from different virus strains.
Georg-Fries B; Mueller-Lantzsch N
Med Microbiol Immunol; 1982; 171(1):11-21. PubMed ID: 6289060
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of Epstein-Barr virus membrane antigens defined with monoclonal antibodies.
Yokochi T; Clark EA; Kimura Y
Virology; 1986 Jan; 148(1):114-20. PubMed ID: 3002025
[TBL] [Abstract][Full Text] [Related]
25. An unusually high-titer human anti-Epstein Barr virus (EBV) serum and its use in the study of EBV-specific proteins synthesized in vitro and in vivo.
Edson CM; Cohen LK; Henle W; Strominger JL
J Immunol; 1983 Feb; 130(2):919-24. PubMed ID: 6294181
[TBL] [Abstract][Full Text] [Related]
26. Characterization of Epstein-Barr virus nuclear antigen(s) in different cell lines by radioimmunoelectrophoresis.
Sculley TB; Spelsberg TC; Pearson GR
Intervirology; 1984; 22(4):191-200. PubMed ID: 6096291
[TBL] [Abstract][Full Text] [Related]
27. Papain solubilization of the Epstein-Barr virus-induced membrane antigen.
Pearson GR; Qualtiere LF
J Virol; 1978 Oct; 28(1):344-51. PubMed ID: 81320
[TBL] [Abstract][Full Text] [Related]
28. Production and characterization of monoclonal antibodies against the Epstein-Barr virus membrane antigen.
Strnad BC; Schuster T; Klein R; Hopkins RF; Witmer T; Neubauer RH; Rabin H
J Virol; 1982 Jan; 41(1):258-64. PubMed ID: 6177865
[TBL] [Abstract][Full Text] [Related]
29. Differential induction of Epstein-Barr virus-related antigens in human lymphoblastoid cells by virus-mediated cell-to-cell contact.
Matsuo T; Yamamoto K; Osato T
Int J Cancer; 1976 Apr; 17(4):423-8. PubMed ID: 179955
[TBL] [Abstract][Full Text] [Related]
30. Immunochemical characterization of Epstein-Barr virus-associated early and late antigens in n-butyrate-treated P3HR-1 cells.
Kallin B; Luka J; Klein G
J Virol; 1979 Dec; 32(3):710-6. PubMed ID: 229261
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus-induced proteins. IV. Characterization of an EBV-associated phosphopolypeptide.
Mueller-Lantzsch N; Yamamoto N
J Gen Virol; 1981 Aug; 55(Pt 2):333-41. PubMed ID: 6270267
[TBL] [Abstract][Full Text] [Related]
32. Immunologic identification of Epstein-Barr virus early antigen in a P3HR-1 cell extract.
Veltri RW; Wainwright WH; Sprinkle PM
J Natl Cancer Inst; 1976 Aug; 57(2):245-53. PubMed ID: 187767
[TBL] [Abstract][Full Text] [Related]
33. An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid cell lines.
Dillner J; Kallin B; Alexander H; Ernberg I; Uno M; Ono Y; Klein G; Lerner RA
Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6641-5. PubMed ID: 3018741
[TBL] [Abstract][Full Text] [Related]
34. Leukocyte migration inhibition detects cross-reacting antigens between cells transformed by Epstein-Barr virus (EBV) and EBV-like simian viruses.
Szigeti R; Rabin H; Timar L; Klein G
Intervirology; 1986; 26(3):121-8. PubMed ID: 3034820
[TBL] [Abstract][Full Text] [Related]
35. Immunoprecipitation of Epstein-Barr virus EBNA1 protein using human polyclonal serum.
Wang SC; Hammarskjöld ML; Klein G
J Virol Methods; 1986 Jul; 13(4):323-32. PubMed ID: 3018021
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of Epstein-Barr virus (EBV) release from the P3HR-1 Burkitt's lymphoma cell line by a monoclonal antibody against a 200,000 dalton EBV membrane antigen.
Sairenji T; Reisert PS; Spiro RC; Connolly T; Humphreys RE
J Exp Med; 1985 May; 161(5):1097-111. PubMed ID: 2580934
[TBL] [Abstract][Full Text] [Related]
37. Intracellular state of Epstein-Barr virus DNA in producer cell lines.
Gussander E; Adams A
J Gen Virol; 1979 Nov; 45(2):331-40. PubMed ID: 232128
[TBL] [Abstract][Full Text] [Related]
38. Characterization of a 75-kDa Epstein-Barr virus capsid protein using a new monoclonal antibody H250.
Sanchez-Pinel A; Bernad J; Rives H; Icart J; Didier J
Res Virol; 1989; 140(6):531-43. PubMed ID: 2559442
[TBL] [Abstract][Full Text] [Related]
39. Characterization of two related Epstein-Barr virus-encoded membrane proteins that are differentially expressed in Burkitt lymphoma and in vitro-transformed cell lines.
Modrow S; Wolf H
Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5703-7. PubMed ID: 3016715
[TBL] [Abstract][Full Text] [Related]
40. Antigenic differences between the membrane antigen polypeptides determined by different EB virus isolates.
Franklin SM; North JR; Morgan AJ; Epstein MA
J Gen Virol; 1981 Apr; 53(Pt 2):371-6. PubMed ID: 6167667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
